Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).

Authors:
Maruki Y; Morizane C; Arai Y; Ikeda M; Ueno M and 21 more

Journal:
J Gastroenterol

Publication Year: 2020

DOI:
10.1007/s00535-020-01735-2

PMCID:
PMC7932978

PMID:
33106918

Journal Information

Full Title: J Gastroenterol

Abbreviation: J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This research was supported in part by the Ministry of Health, Labour and Welfare (MHLW) Health Labour Sciences Research Grants: “Research on the establishment of treatment for biliary tract cancer” and “Clinical Trial on Development of New Drugs and Medical Devices”, MEXT KAKENHI (18K07956) and The National Cancer Center Research and Development Fund 23-A-15."

Evidence found in paper:

"This study was approved by the institutional review boards from all participating institutions. Written consent was obtained directly from patients, and the study was conducted in accordance with the Declaration of Helsinki, the “Ethical Guidelines for Epidemiology Research,” and the “Ethical Guidelines for Medical and Health Research Involving Human Subjects.” This trial was registered in UMIN Clinical Trials Registry (UMIN-CTR) under the registration number UMIN000014767."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025